Kajian klinikal Limfedema di Texas
7 kajian untuk Limfedema sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
- UT MD Anderson Cancer Center, Houston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07855627Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
- MD Anderson Cancer Center, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989099Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
- MD Anderson Cancer Center, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06494111Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
- UTHealth Houston (The University of Texas Health Science Center at Houston), Houston
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07613931Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- MD Anderson Cancer Center, Houston
Mengambil pesertaFasa 2
Semua umur · Wanita · Dikemas kini 24 Jul 2026 · NCT06912763A Real-World Registry of Chronic Wounds and Ulcers
- US Wound Registry, The Woodlands
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 16 Jul 2025 · NCT02280733LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
- MD Anderson, Houston
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 11 Mac 2025 · NCT04606030Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.